This paper highlights the status of the Indian biopharmaceutical industry and also makes a comparison with the global scenario. It also discusses the current situation regarding patenting biopharmaceuticals in India. [GIDR WP no. 168].

A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal...